Skin Treatment Developer Can Use Lender Cash In Ch. 11
Skin treatment development company Sienna Biopharmaceuticals Inc. received court authorization Wednesday in Delaware to access the cash of its prepetition lenders in order to fund its trip through Chapter 11....To view the full article, register now.
Already a subscriber? Click here to view full article